National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Zileuton
Synonyms

N-(1-Benzo[b]thien-2-ylethyl)-N-hydroxyurea

(+-)-N-Hydroxy-N-(1-benzo[b]thien-2-ylethyl)-urea

ZILEUTON

Zileuton

Zyflo

zileuton

Definitions

A synthetic derivative of hydroxyurea with antiasthmatic properties. The leukotriene inhibitor zileuton blocks 5-lipoxygenase, which catalyzes the formation of leukotrienes from arachidonic acid; causes bronchodilation; decreases bronchial mucous secretion and edema; and may prevent or decrease the symptoms of asthma. (NCI04)

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26667

Accepted_Therapeutic_Use_For

Prevention and Chronic treatment of Asthma

ALT_DEFINITION

A substance that is used to prevent asthma symptoms and that is being studied in the prevention of lung cancer. It belongs to the family of drugs called leukotriene blockers.

CAS_Registry

111406-87-2

CHEBI_ID

CHEBI:10112

Chemical_Formula

C11H12N2O2S

code

C26667

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

CTRP

FDA

DEFINITION

A synthetic derivative of hydroxyurea with antiasthmatic properties. The leukotriene inhibitor zileuton blocks 5-lipoxygenase, which catalyzes the formation of leukotrienes from arachidonic acid; causes bronchodilation; decreases bronchial mucous secretion and edema; and may prevent or decrease the symptoms of asthma. (NCI04)

Display_Name

Zileuton

FDA_UNII_Code

V1L22WVE2S

FULL_SYN

N-(1-Benzo[b]thien-2-ylethyl)-N-hydroxyurea

(+-)-N-Hydroxy-N-(1-benzo[b]thien-2-ylethyl)-urea

ZILEUTON

Zileuton

Zyflo

zileuton

label

Zileuton

Legacy Concept Name

Zileuton

NCI_Drug_Dictionary_ID

285649

NSC Number

730712

PDQ_Closed_Trial_Search_ID

285649

PDQ_Open_Trial_Search_ID

285649

Preferred_Name

Zileuton

prefixIRI

Thesaurus:C26667

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0081408

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1322

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C063449 RH-MESH LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#15352 OCHV LOOM
https://go.drugbank.com/drugs/DB00744 MDM LOOM
http://stirdf.jst.go.jp/id/200907003636361797 IOBC LOOM
http://purl.bioontology.org/ontology/RXNORM/40575 RXNORM LOOM
http://purl.bioontology.org/ontology/VANDF/4021009 VANDF LOOM
http://purl.jp/bio/4/id/200906009024846974 IOBC LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0081408 OCHV LOOM
http://purl.bioontology.org/ontology/MESH/C063449 MESH LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/108617005 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000285649 PDQ LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 CCONT LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 HOIP LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 TXPO LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 NIFSTD LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_10112 OBA LOOM
http://www.drugbank.ca/drugs/DB00744 FTC LOOM
http://purl.obolibrary.org/obo/NCIT_C26667 BERO LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148478 NDFRT LOOM